Summary

Other Scenarios:

Buyer: The Procter & Gamble Company (PG) Last Price: 67.81 Market Cap.: 211.30B
Target: BHP Billiton plc (ADR) (BBL) Last Price: 60.30 Market Cap.: 175.78B

Lines of Business Summary:

Product Summary:

Overlap & Complementary Sectors

Sector Buyer Target # of Focused Companies
*Healthcare   930
*Media   148
Energy   358
Manufacturing 1,192

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Sample Products in Similar Lines of Business

Sample Products in Complementary Lines of Business
Buyer (Total: 75)
  • Folgers
  • Millstone
  • Iams
  • Eukanuba
Target (Total: 7)
  • BHP Billiton Aluminum
  • BHP Billiton Carbon Steel Materials
  • BHP Billiton Energy Coal
  • BHP Billiton Base Metals
Buyer
  • Vicks Children's NyQuil (Chlorpheniramine Maleate/Pseudoephedrine HCl/Dextromethorphan HBr)
  • Vicks Pediatric Formula 44M Multi Symptom Cough & Cold (Chlorpheniramine Maleate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide)
  • Vicks 44M Cough, Cold & Flu Relief (Chlorpheniramine Maleate/Dextromethorphan Hydrobromide/Pseudoephedrine Hydrochloride/Acetaminophen)
  • Vicks NyQuil Multi Symptom Cold/Flu Relief (Doxylamine Succinate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide/Acetaminophen)
Target
  • BHP Billiton Petroleum

Business Relationship Summary:

Top Key Suppliers

Top Key Customers
Buyer (Total: 64)
  • Nastech Pharmaceutical Co. Inc. (NSTK)
  • Alexion Pharmaceuticals, Inc. (ALXN)
  • Multi-Color Corp. (LABL)
  • Tredegar Corporation (TG)
Target (Total: 3)
  • Century Aluminum Company (CENX)
  • SAP AG (ADR) (SAP)
  • Allis-Chalmers Energy Inc. (ALY)
Buyer (Total: 10)
  • Wal-Mart Stores, Inc. (WMT)
  • sanofi-aventis (ADR) (SNY)
  • Sally Beauty Holdings, Inc. (SBH)
  • 99 Cents Only Stores (NDN)
Target (Total: 3)
  • CLP Holdings Limited (ADR) (CLPHY)
  • AGL Resources Inc. (ATG)
  • Denison Mines Corp. (DNN)

Key Financial Summary:

Key Metrics

  Buyer Target
Number of Employees 138,000 33,184
Revenue Per Employee 560,143.3 n/a
Total Revenue 19,272.0 n/a
Total Expenses 15,872.0 n/a
Other Revenue 0.0 n/a
Cost of Revenue 9,477.0 n/a
SG&A Expense 6,395.0 n/a
Research & Development 0.0 n/a
Other Operating Expense 0.0 n/a
Operating Income 3,400.0 n/a
Unusual Income 0.0 n/a
LT Debt to Capital 25.93 n/a
Fwd P/E 19.44 13.34
Fwd P/Rev 2.59 4.57
Book Value 65,354.0 n/a
Curr Portion of LTD/Cap Lease 12,039.0 n/a

Individual Company Summary

Focused

Buyer

Focused (): Manufacturing > Consumer Manufacturing > Personal Care and Cleaning Products

Target

Focused (): Manufacturing > Materials > Mining

Business Description

Buyer

The Procter & Gamble Company (P&G) is focused on providing branded consumer goods products. The Company markets its products in more than 180 countries. During the fiscal year ended June 30, 2007 (fiscal 2007), the Company was organized into three global business units: Beauty and Health, Household Care and Gillette GBU. P&G had seven segments under United States Generally Accepted Accounting Principles: Beauty; Health Care; Fabric Care and Home Care; Snacks, Coffee and Pet Care; Baby Care and Family Care; Blades and Razors, and Duracell and Braun. In September 2006, the Company's Sure brand (an antiperspirant and deodorant brand) was acquired by Innovative Brands, LLC. In January 2007, P&G acquired HDS Cosmetics Lab Inc., which manufactures and markets Doctor's Dermatologic Formula (DDF) skin care.

Target

BHP Billiton plc is a diversified resources group. The Company's customer sector groups (CGS) are organized into seven business units: petroleum, which explores for, produces, processes and markets hydrocarbons; aluminium, which explores for and mines bauxite and processes and markets aluminium and alumina; base Metals, which explores for, mines, processes and markets copper, silver, uranium, and copper by-products, including gold and molybdenum; carbon steel materials, which explores for, mines, processes and markets metallurgical coal, iron ore and manganese; diamonds and specialty products, which explores for and mines diamonds and titanium minerals; energy coal, which explores for, mines, processes and markets energy coal for use in electricity generation, and stainless steel materials, which explores for, mines, processes and markets nickel. On August 22, 2006, The Australian Gas Light Company acquired of a 50% interest in the Moranbah Gas Project from BHP Billiton plc.

Deal Summary

Key Ratios

  Buyer Target
Gross Margin % 52.03 84.31
Operating Margin % 20.2 45.63
Quick Ratio 0.4 n/a
Current Ratio 0.78 n/a
Coverage Ratio -0.08 0.02
Total Assets 138,014.0 n/a
Return on Equity % 15.49 n/a
Return on Assets % 7.49 n/a
Cash+ ST Inv. Per Share 1.65 n/a
Total Debt 35,414.0 0.0
Total Debt to Equity % 53.05 n/a
Total Debt to Tangible Equity % n/a n/a
Debt to Asset % 25.66 n/a

Product Summary

Sector Buyer Target
*Healthcare  
Biopharmaceuticals  
Allergies
The Allergies Subsector includes therapeutics that treat exaggerated immune reaction induced by exposure to a foreign substance.
  
Cardiovascular System
The Cardiovascular System Subsector includes therapeutics that treat disorders affecting the heart and blood vessels.
  
Dermatology
The Dermatology Subsector includes therapeutics that treat disorders affecting the skin.
  
Digestive System
The Digestive System Subsector includes therapeutics that treat disorders affecting the digestive system.
  
Immunology
The Immunology Subsector includes therapeutics that treat disorders affecting the immune system.
  
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
  
Musculoskeletal System
The Musculoskeletal System Subsector includes therapeutics that treat disorders of the bones, joints, ligaments, tendons, and soft tissue involved with them.
  
Neurology
The Neurology Subsector includes therapeutics that treat disorders of the central nervous system, including the brain, spinal cord, and nerves.
  
Obstetrics/Gynecology
The Obstetrics/Gynecology Subsector includes therapeutics that treat female genital disorders, pregnancy, and childbirth.
  
Respiratory System
The Respiratory System Subsector includes therapeutics that treat disorders affecting both the upper and lower respiratory tract, including the nose, throat, larynx, trachea, bronchi, and lungs.
  
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
  
Urology
The Urology Subsector includes therapeutics that treat diseases of the kidney, urinary tract, bladder, and the male reproductive system.
  
Medical Devices  
Medical Supplies
The Medical Supplies Subsector includes basic and consumable products that are widely used in healthcare settings.
  
Orthopedics
The Orthopedics Subsector includes medical devices that diagnose and treat musculoskeletal diseases involving muscles, bones and joints.
  
Nutritional Health  
Dietary/Naturopathic Supplements
The Dietary/Naturopathic Subsector includes nutritional biochemicals and nutrients derived from natural sources that are intended to support health.
  
Scientific Products  
Consumables
The Consumables Subsector includes chemicals, reagents, standards, media, and disposable labware that are normally depleted or worn out by continuous use.
  
*Media  
Entertainment/Programming  
Television, Film and Video
Companies involved in the production, post-production, and distribution of Motion Pictures and Television programming.
  
Energy  
Upstream  
Crude Oil and Natural Gas Exploration/Production
Companies that engage in exploration and production of crude oil and natural gas from land or sea oilfields.
  
Manufacturing
Consumer Manufacturing  
Food, Beverage and Agriculture
Includes agricultural inputs like livestock and crops, as well as processed food and beverage products. Tobacco growers and cigarette manufacturers are also included.
  
Household Products
The Household Products sector includes furniture and other home and institutional decorative items, major and small appliances, kitchenware, and other related products.
  
Personal Care and Cleaning Products
Companies engaged in the manufacturing of personal care products, such as cosmetics, fragrances, skin lotion, shampoo and other toiletries; and household cleaning products, such as window/surface cleaner, and table polish.
  
Materials  
Metal and Mineral Products
The Metal and Mineral Products Subsector includes companies that produce primary and industrial metal products, as well as clay, ceramic and glass products.
  
Mining
The Mining Subsector includes companies that extract naturally occurring metals and minerals from mines, such as coal, base and precious metals and other nonmetallic minerals.
  

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Product Details

Sector Buyer Target
*Healthcare  
Biopharmaceuticals  
Allergies  
Upper Respiratory  
Antihistamines/Decongestants/Antitussives
Therapeutics that treat allergic reactions by suppressing inflammation, reducing mucous build up, and relieving or preventing coughs.

Buyer Products:

  • Vicks Children's NyQuil (Chlorpheniramine Maleate/Pseudoephedrine HCl/Dextromethorphan HBr)
  • Vicks Pediatric Formula 44M Multi Symptom Cough & Cold (Chlorpheniramine Maleate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide)
  
Antihistamines/Decongestants/Antitussives/Analgesics/Antipyretics
Therapeutics that treat allergic reactions by suppressing inflammation, reducing mucous build up, relieving or preventing coughs, relieving pain, and reducing fever.

Buyer Products:

  • Vicks 44M Cough, Cold & Flu Relief (Chlorpheniramine Maleate/Dextromethorphan Hydrobromide/Pseudoephedrine Hydrochloride/Acetaminophen)
  • Vicks NyQuil Multi Symptom Cold/Flu Relief (Doxylamine Succinate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide/Acetaminophen)
  
Cardiovascular System  
Heart Disorders  
Arrhythmia  
Potassium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of potassium into heart muscle cells.

Buyer Products:

  • Azimilide
  
Dermatology  
Acne  
Vulgaris  
Retinoids/Vitamin A Analogs
Therapeutics that treat acne by helping in cell differentiation as well as prevent cell proliferation.

Buyer Products:

  • Tazorac (Tazarotene)
  
Lesion/Scaling Disorders  
Psoriasis  
Retinoids/Vitamin A Analogs
Therapeutics that treat a chronic autoimmune disease characterized by softening, separating, and causing the shedding of the horny layer of the skin by modulating cell differentiation and proliferation.

Buyer Products:

  • Tazorac (Tazarotene)
  
Digestive System  
Gastrointestinal Tract Disorders  
Gastroduodenal Disorders  
Peptic Ulcers  
Duodenal  
Antisecretory Agents/Nitroimidazoles/Tetracyclines
Therapeutics that treat peptic ulcers by preventing the secretion of acid as well as treating infections by using antibiotics.

Buyer Products:

  • Helidac (Bismuth Subsalicylate/Metronidazole/Tetracycline Hydrochloride)
  
Gastroesophageal Disorders  
Acid Indigestion/Heartburn  
Proton Pump Inhibitors
Therapeutics that treat heartburn by inhibiting the action of the membrane protein involved in the final steps of triggering acid release into the stomach.

Buyer Products:

  • Prilosec OTC (Omeprazole)
  
Intestinal Disorders  
Constipation  
Chronic  
Bulk-Forming Agents
Therapeutics that treat constipation by stimulating the formation of bodies of feces that are able to be passed through the bowels.

Buyer Products:

  • Metamucil (Psyllium)
  
Irregular Bowel Movements  
Bulk-Forming Agents
Therapeutics that treat constipation by stimulating the formation of bodies of feces that are able to be passed through the bowels.

Buyer Products:

  • Metamucil (Psyllium)
  
Diarrhea  
Antisecretory Agents
Therapeutics that treat diarrhea by bringing fluid movement within the intestine to normal levels.

Buyer Products:

  • Pepto Bismol (Bismuth Subsalicylate)
  
Inflammatory Bowel Disease (IBD)  
Ulcerative Colitis  
Cyclooxygenase Inhibitors (COX Inhibitors)/Lipoxygenase Inhibitors
Therapeutics that treat ulcerative colitis by inhibiting the actions of the two enzymes, cyclooxygenase and lipoxygenase.

Buyer Products:

  • Asacol (Mesalamine)
  
Immunology  
Autoimmune Disorders  
Inflammatory Bowel Disease (IBD)  
Ulcerative Colitis  
Cyclooxygenase Inhibitors (COX Inhibitors)/Lipoxygenase Inhibitors
Therapeutics that treat inflammation of the colon and rectum by blocking the action of cyclooxygenase and lipoxygenase.

Buyer Products:

  • Asacol (Mesalamine)
  
Psoriasis  
Retinoids/Vitamin A Analogs
Therapeutics that treat a chronic autoimmune disease characterized by softening, separating, and causing the shedding of the horny layer of the skin by modulating cell differentiation and proliferation.

Buyer Products:

  • Tazorac (Tazarotene)
  
Infectious Diseases  
Bacterial  
Antibacterial Agents  
Narrow Spectrum  
Digestive System  
Heliobacter pylori  
Antisecretory Agents/Nitroimidazoles/Tetracyclines
Therapeutics treat digestive infections caused by Helicobacter pylori bacteria by inhibiting the action of the membrane protein involved in the final steps of triggering acid release into the stomach.

Buyer Products:

  • Helidac (Bismuth Subsalicylate/Metronidazole/Tetracycline Hydrochloride)
  
Urology  
Urinary Tract Infections (UTI)  
Antibacterial Agents (Antibiotics)  
Nitrofurantoins
Therapeutics that treat bacterial infections of the urinary tract by inactivating/altering bacterial proteins and other macromolecules.

Buyer Products:

  • Macrodantin (Nitrofurantoin)
  • Macrobid (Nitrofurantoin)
  
Musculoskeletal System  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of skeletal system disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Parathyroid Hormone (PTH 1-34) Nasal Spray
  
Skeletal Disorders  
Bone Disorders  
Heterotopic Ossification  
Osteoclast Bone Resorption Inhibitors
Therapeutics that treat ossification by inhibiting the loss of bone material by osteoclasts.

Buyer Products:

  • Didronel (Etidronate Disodium)
  
Osteoporosis  
Osteoclast Bone Resorption Inhibitors
Therapeutics that treat osteoporosis by preventing loss of bone mass due to osteoclasts.

Buyer Products:

  • Actonel (Risedronate Sodium)/Once Weekly Actonel (Risedronate Sodium)/Actonel With Calcium
  
Paget`s Disease  
Osteoclast Bone Resorption Inhibitors
Therapeutics that treat paget's disease by inhibiting the loss of bone material by osteoclasts.

Buyer Products:

  • Didronel (Etidronate Disodium)
  • Actonel (Risedronate Sodium)/Once Weekly Actonel (Risedronate Sodium)/Actonel With Calcium
  
Neurology  
Neurological Disorders  
Spasticity (Spinal Shock)  
Calcium Channel Inhibitors
Therapeutics that treat spasticity by preventing the release of calcium from the sarcoplasmic reticulum which results in reduced involuntary muscle contractions.

Buyer Products:

  • Dantrium/Dantrium I.V. (Dantrolene Sodium)
  
Obstetrics/Gynecology  
Female Genital Disorders  
Sexual Dysfunction  
Androgens
Therapeutics that treat female sexual dysfunction by providing male sex hormone, such as testosterone, that is important for the normal functioning of the female reproductive system.

Buyer Products:

  • Intrinsa (Testosterone Patch)
  
Respiratory System  
Upper Respiratory Tract Disorders  
Coughs/Colds  
Amphetamines
Therapeutics that treat coughs and colds by helping to relieve nasal congestion.

Buyer Products:

  • Vicks Vapor Inhaler (1-Desoxyephedrine)
  
Antihistamines/Antitussives
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Buyer Products:

  • Vicks NyQuil Cough (Doxylamine Succinate/Dextromethorphan Hydrobromide)
  
Antihistamines/Decongestants/Antitussives
Therapeutics that treat coughs and colds by suppressing inflammation, reducing mucous build up, and relieving or preventing coughs.

Buyer Products:

  • Vicks Children's NyQuil (Chlorpheniramine Maleate/Pseudoephedrine HCl/Dextromethorphan HBr)
  • Vicks Pediatric Formula 44M Multi Symptom Cough & Cold (Chlorpheniramine Maleate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide)
  
Antihistamines/Decongestants/Antitussives/Analgesics/Antipyretics
Therapeutics that treat coughs and colds by suppressing inflammation, reducing mucous build up, relieving or preventing coughs, relieving pain, and reducing fever.

Buyer Products:

  • Vicks 44M Cough, Cold & Flu Relief (Chlorpheniramine Maleate/Dextromethorphan Hydrobromide/Pseudoephedrine Hydrochloride/Acetaminophen)
  • Vicks NyQuil Multi Symptom Cold/Flu Relief (Doxylamine Succinate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide/Acetaminophen)
  
Antitussives
Therapeutics that relieve or prevent coughs.

Buyer Products:

  • Vicks 44 Cough Relief (Dextromethorphan Hydrobromide)
  
Antitussives/Expectorants
Therapeutics that treat coughs and colds by suppressing coughs and helping ejection of the mucous.

Buyer Products:

  • Vicks 44E/Vicks Pediatric Formula 44E (Dextromethorphan HBr/Guaifenesin)
  
Decongestants
Therapeutics that treat coughs and colds by reducing mucous build up.

Buyer Products:

  • Vicks Inhaler (Levmetamfetamine)
  • Vicks Sinex 12 Hour (Oxymetazoline)
  • Vicks Sinex (Phenylephrine Hydrochloride)
  
Decongestants/Antitussives
Therapeutics that treat coughs and colds by reducing mucous build up and suppressing the cough.

Buyer Products:

  • Vicks 44D Cough & Head Congestion Relief (Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide)
  
Decongestants/Antitussives/Expectorants/Analgesics/Antipyretics
Therapeutics that treat coughs and colds by reducing mucous build up, suppressing the cough, helping in the ejection of mucous and helping relieve fever and pain.

Buyer Products:

  • Vicks DayQuil Multi Symptom Cold/Flu Relief (Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide/Guaifenesin/Acetaminophen)
  
Decongestants/Expectorants
Therapeutics that treat coughs and colds by reducing mucous build up and help in ejection of mucous.

Buyer Products:

  • Vicks DayQuil Sinus Presure & Pain Relief (Phenylpropanolamine/Guaifenesin)
  
Expectorants/Opioids
Therapeutics that treat coughs and colds by suppressing the cough and helping in the ejection of the mucous.

Buyer Products:

  • Brontex (Guaifenesin/Codeine Phosphate)
  
Surgery  
General  
Complications  
Hyperthermia  
Calcium Channel Inhibitors
Therapeutics that treat hyperthermia by preventing the release of calcium from the sarcoplasmic reticulum which results in inhibits the catabolic processes responsible for increase in temperature.

Buyer Products:

  • Dantrium/Dantrium I.V. (Dantrolene Sodium)
  
Urology  
Urological Disorders  
Bladder  
Urinary Frequency/Urge Incontinence  
Anticholinergic Agents
Therapeutics that treat the inability to control urinary excretory functions by blocking the actions of choline and other cholinergic agents.

Buyer Products:

  • Enablex (Darifenacin)
  
Medical Devices  
Medical Supplies  
Diagnostic  
Temperature  
Thermometers
Medical instruments designed to measure the temperature in patients

Buyer Products:

  • Vicks Thermometer Series
  
Orthopedics  
Treatment  
Pain Management  
General Purpose  
Dry Heat Therapy
Devices that control the of use dry heat to ease pain associated with musculoskeletal injuries.

Buyer Products:

  • ThermaCare Heatwrap Series
  
Nutritional Health  
Dietary/Naturopathic Supplements  
General Health
Products consisting of dietary/naturopathic supplements that are intended to support general health.

Buyer Products:

  • The Procter & Gamble Company
  
Scientific Products  
Consumables  
Bioanalytical Chemistry  
Cell Biology  
Cell Proliferation  
Kits
Cell proliferation consumables that are a collection of reagents, standards, and other consumables assembled for used in various biological analyses.

Buyer Products:

  • CellCube System
  • E-Cube Culture System Kit
  
*Media  
Entertainment/Programming  
Television, Film and Video  
Production  
Television  
Domestic  
Soap Opera
Shows depicting the interconnected lives of many characters often in a sentimental, melodramatic way.

Buyer Products:

  • Procter & Gamble Productions
  
Energy  
Upstream  
Crude Oil and Natural Gas Exploration/Production  
Americas  
Latin America
Companies that engage in Oil/Gas exploration and production in Latin America.

Target Products:

  • BHP Billiton Petroleum
  
U.S.  
Southern Region  
Gulf of Mexico
Companies that engage in Oil/Gas exploration and production in the Gulf of Mexico.

Target Products:

  • BHP Billiton Petroleum
  
Asia/Pacific  
Australia/New Zealand
Companies that engage in Oil/Gas exploration and production in Australia/New Zealand.

Target Products:

  • BHP Billiton Petroleum
  
Other Asia/Pacific
Companies that engage in Oil/Gas exploration and production in other areas of the Asia/Pacific region.

Target Products:

  • BHP Billiton Petroleum
  
Europe  
North Sea
Exploration, extraction, and production of crude oil and natural gas from offshore oilfields located in the North Sea. Norway has the largest single reserves in this region, followed by the Untied Kingdom. Germany, Denmark, and the Netherlands possess smaller fields here.

Target Products:

  • BHP Billiton Petroleum
  
Other Europe
Exploration, extraction, and production of crude oil and natural gas from oilfields located in other regions of Europe.

Target Products:

  • BHP Billiton Petroleum
  
Middle East/Africa
Companies that engage in Oil/Gas exploration and production in the Middle East/Africa region.

Target Products:

  • BHP Billiton Petroleum
  
Manufacturing
Consumer Manufacturing  
Food, Beverage and Agriculture  
Beverages  
Non-Alcoholic Beverages  
Coffee/Tea
Coffee and Tea Manufacturing.

Buyer Products:

  • Folgers
  • Millstone
  
Food  
Pet Food
Food for dogs and cats.

Buyer Products:

  • Iams
  • Eukanuba
  
Sweets/Snacks  
Snack Foods
Manufacturers of Potato Chips, Peanuts, Trail Mix, and Cheese Snacks.

Buyer Products:

  • Pringles
  
Household Products  
Household Appliances and Tools  
Other Household Products  
Brooms, Brushes, and Mops
Brooms, brushes, mops, and other manual cleaning equipment.

Buyer Products:

  • Swiffer
  
Small Electrical Appliances/Accessories  
Consumer Batteries
Relatively small, portable batteries used to power all varieties of consumer electronic devices. These one-time-use or rechargeable batteries store electric energy and can be used to power various devices ranging from CD players to cell phones. The most popular battery types include: lithium (Li), lithium ion (Li-ion), nickel-metal hybrid (NiMH), and nickel-cadmium (NiCAD). Flashlights are included at this level.

Buyer Products:

  • Duracell
  
Kitchen/Bath Appliances
Electrical Kitchen/Bath Appliances, including toasters; juicemakers; and food blenders, as well as electrical toothbrushes, hairdryers, and electric massagers.

Buyer Products:

  • Oral-B
  
Personal Care and Cleaning Products  
Absorbent Products
Absorbent products, including tampons, pads, and diapers.

Buyer Products:

  • Tampax
  • Always
  • Pampers
  
Anti-Perspirant
Anti-Perspirant and/or deodorant.

Buyer Products:

  • Secret
  • Old Spice
  
Cosmetics
Companies engaged in the manufacturing of cosmetics, such as lipstick, powders, and other make-up.

Buyer Products:

  • Olay
  • Max Factor
  • CoverGirl
  
Fragrances
Companies engaged in the manufacturing of fragrances, such as perfume and cologne.

Buyer Products:

  • Hugo Boss
  • Giorgio Beverly Hills
  
Hair Care
Companies engaged in the manufacturing of hair care products, such as shampoo, conditioner, hair dye, hair spray, styling gel, and mousse. Also includes hair accessories, such as pins, clips, and curlers.

Buyer Products:

  • Clairol
  • Herbal Essences
  • Physique
  • Infusium 23
  • Aussie
  • Pantene
  • Head & Shoulders
  
Household Cleaning Products
Chemical-based household cleaning products, such as detergent and surface cleaner. Also includes automotive cleaning products.

Buyer Products:

  • Tide
  • Mr. Clean
  • Downy
  • Febreze
  • Swiffer
  
Oral Care
Oral Care products, including Toothpaste, Mouthwash, and denture adhesive.

Buyer Products:

  • Fixodent
  
Sanitary/Personal Care Paper
Companies engaged in the manufacturing of sanitary/personal care paper such as napkins and tissues.

Buyer Products:

  • Charmin
  • Bounty
  • Puffs
  
Skin Care
Companies engaged in the manufacturing of skin care products, such as suntan lotion, skin lotion, sanitizer, shaving cream, and moisturizer. Also includes manufacturers of non-electrical shaving equipment.

Buyer Products:

  • Doctor's Dermatologic Formula
  • Gillette
  • Olay
  • Noxzema
  
Soap/Body Wash
Soap, Body Wash, and Shower Gel.

Buyer Products:

  • Camay
  • Ivory
  • Safeguard
  
Materials  
Metal and Mineral Products  
Metal  
Primary Metals  
Alumina and Aluminum Products  
Alumina
Companies engaged in refining alumina from bauxite.

Target Products:

  • BHP Billiton Aluminum
  
Aluminum
Includes companies engaged in the manufacturing of aluminum from alumina.

Target Products:

  • BHP Billiton Aluminum
  
Mining  
Coal
Includes companies in the leasing of coal mines and the mining and processing of coal.

Target Products:

  • BHP Billiton Carbon Steel Materials
  • BHP Billiton Energy Coal
  
Metal Ore Mining  
Base Metals (Non-Ferrous/Ferrous Metals)  
Bauxite
Includes companies engaged in bauxite (aluminum ore) mining.

Target Products:

  • BHP Billiton Aluminum
  
Copper
Includes companies engaged in copper mining.

Target Products:

  • BHP Billiton Base Metals
  
Iron
Includes companies engaged in iron mining.

Target Products:

  • BHP Billiton Carbon Steel Materials
  
Lead
Includes companies engaged in lead mining.

Target Products:

  • BHP Billiton Base Metals
  
Nickel
Includes companies engaged in nickel mining.

Target Products:

  • BHP Billiton Stainless Steel Materials
  
Other Non-Ferrous and Ferrous Metals
Includes companies engaged in other non-ferrous (i.e. non-iron based) and ferrous metals mining, such as molybdenum, chromium, manganese, cadmium, and cobalt.

Target Products:

  • BHP Billiton Stainless Steel Materials
  • BHP Billiton Carbon Steel Materials
  
Uranium-Radium-Vanadium
Includes companies engaged in uranium, radium, and vanadium mining.

Target Products:

  • BHP Billiton Base Metals
  
Zinc
Includes companies engaged in zinc mining.

Target Products:

  • BHP Billiton Base Metals
  
Precious Metals  
Gold  
Asia  
Australia
Includes companies engaged in gold mining and exploration in Australia, including New Zealand and Papua New Guinea.

Target Products:

  • BHP Billiton Base Metals
  
Silver
Includes companies engaged in silver mining and exploration.

Target Products:

  • BHP Billiton Base Metals
  
Nonmetallic Mineral Mining  
Diamond
Includes companies engaged in the mining and production of diamonds.

Target Products:

  • BHP Billiton Diamonds & Specialty Products
  

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Relationship Details

Key Competitors

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  GlaxoSmithKline plc (ADR) n/a 150,459.597 13.70 13.62 3.25 3.31 12.06
PepsiCo, Inc. n/a 112,394.142 19.03 20.74 3.10 2.93 11.41
Target
  Exxon Mobil Corporation n/a 491,787.026 12.21 12.73 1.31 1.34 4.23
Royal Dutch Shell plc (ADR) n/a 260,977.639 9.60 n/a 0.82 n/a 2.43
BP plc (ADR) n/a 218,385.924 8.40 11.13 0.80 0.71 3.04
Chevron Corporation n/a 193,239.515 10.23 10.79 0.94 0.93 2.78
TOTAL S.A. (ADR) n/a 175,823.241 11.48 11.03 0.99 0.94 3.27
ConocoPhillips n/a 138,750.149 12.71 8.90 0.75 0.81 2.55
Companhia Vale do Rio Doce (ADR) n/a 131,682.574 13.43 11.13 4.65 3.98 5.11
Rio Tinto plc (ADR) n/a 108,595.962 15.75 12.60 4.54 4.01 5.65
Anglo American plc (ADR) n/a 76,632.883 11.57 12.43 2.26 2.26 3.49
BG Group plc (ADR) n/a 54,598.521 15.97 16.55 3.38 3.69 4.55
Marathon Oil Corporation n/a 38,073.606 7.66 8.70 0.63 0.52 2.67
Freeport-McMoRan Copper & Gold Inc. n/a 37,294.911 15.82 10.25 3.27 2.04 3.59
Alcan Inc. (USA) n/a 36,945.539 19.50 15.83 1.48 1.45 5.01
Barrick Gold Corporation (USA) n/a 32,184.437 30.36 24.57 5.70 5.02 3.83
Alcoa Inc. n/a 31,365.530 13.81 10.86 1.00 0.97 2.94
Newmont Mining Corporation n/a 20,477.284 n/a 48.05 4.00 3.74 3.42
Nucor Corporation n/a 17,091.649 10.35 11.35 1.11 1.04 4.02
United States Steel Corporation n/a 10,833.177 8.40 8.81 0.68 0.64 2.91
Alumina Limited (ADR) n/a 6,723.355 14.65 16.01 2,615.28 n/a 4.78
Cleveland-Cliffs Inc n/a 3,224.870 11.82 13.44 1.61 1.47 3.01
LTV Corporation n/a 0.094 n/a n/a 0.00 n/a n/a
MMC Norilsk Nickel Group n/a n/a n/a n/a n/a n/a n/a
Woodside Petroleum Ltd. n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Dependent Suppliers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Nastech Pharmaceutical Co. Inc. 77.00% 352.738 n/a -7.39 17.45 16.42 5.56
Alexion Pharmaceuticals, Inc. 37.70% 2,293.244 n/a -20.03 138.78 55.38 30.03
Multi-Color Corp. 30.00% 236.520 20.84 19.97 1.06 n/a 4.03
Tredegar Corporation 23.40% 655.306 15.98 17.11 0.58 n/a 1.60
Griffon Corporation 14.00% 436.205 13.82 16.98 0.26 n/a 1.32
Buckeye Technologies Inc. 13.00% 541.960 17.99 13.26 0.70 0.67 2.83
Sonoco Products Company 12.00% 3,386.872 17.28 14.07 0.87 0.85 9.33
Publicis Groupe S.A. (ADR) 10.00% 7,543.253 12.40 14.91 1.23 1.14 n/a
Valassis Communications, Inc. 10.00% 448.656 12.99 8.60 0.30 0.20 n/a
Curis, Inc. 5.00% 53.497 n/a n/a 3.84 3.60 2.51
American Express Company n/a 69,719.179 17.42 17.46 2.34 2.48 6.56
WPP Group plc (ADR) n/a 16,342.844 18.37 15.93 1.36 1.37 n/a
Boston Properties, Inc. n/a 11,579.676 10.17 21.06 7.66 8.27 2.78
Metso Oyj (ADR) n/a 9,013.168 17.74 15.78 1.18 n/a 15.24
Dassault Systemes S.A. (ADR) n/a 7,094.425 27.36 26.04 4.25 4.07 4.53
Owens-Illinois, Inc. n/a 6,192.462 71.09 18.87 0.82 0.82 n/a
Huntsman Corporation n/a 5,803.213 n/a 19.75 0.58 0.60 3.97
BEA Systems, Inc. n/a 5,194.029 36.05 30.38 4.01 3.36 5.07
Focus Media Holding Limited (ADR) n/a 4,749.245 52.74 32.26 19.93 11.13 12.75
Business Objects S.A. (ADR) n/a 4,018.704 48.85 25.92 2.92 2.71 52.44
Crown Holdings, Inc. n/a 3,822.747 10.74 16.23 0.52 0.49 n/a
Central European Media Enterprises Ltd. n/a 3,797.550 58.87 35.03 5.50 5.33 n/a
Target
  Century Aluminum Company 14.70% 1,926.668 32.99 7.36 1.12 1.05 4.27
SAP AG (ADR) n/a 69,334.557 26.29 26.43 5.20 4.91 12.08
Allis-Chalmers Energy Inc. n/a 691.882 12.99 11.84 1.44 1.19 2.98

- Defined by the Company - Defined by Others

Key Customers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Wal-Mart Stores, Inc. 15.00% 176,235.594 14.25 14.16 0.49 0.47 3.70
sanofi-aventis (ADR) n/a 116,041.327 21.97 11.99 2.87 3.01 n/a
Sally Beauty Holdings, Inc. n/a 1,503.840 25.80 28.66 0.61 0.60 n/a
99 Cents Only Stores n/a 752.313 69.21 38.29 0.66 0.62 1.44
Helen of Troy Limited n/a 601.450 11.24 10.41 0.93 0.90 5.65
Prestige Brands Holdings, Inc. n/a 533.535 14.76 14.09 1.66 1.59 n/a
Fred's, Inc. n/a 418.061 16.32 14.50 0.23 0.23 1.11
United-Guardian, Inc. n/a 50.206 14.95 n/a 3.71 n/a 3.65
AMCON Distributing Co. n/a 15.285 8.52 n/a 0.02 n/a n/a
Synergy Brands, Inc. n/a 8.183 n/a n/a 0.10 n/a 1.26
Target
  CLP Holdings Limited (ADR) n/a 16,496.485 11.65 11.50 2.63 2.79 2.48
AGL Resources Inc. n/a 3,103.916 14.44 14.24 1.20 1.13 2.48
Denison Mines Corp. n/a 1,864.719 n/a n/a n/a 26.06 2.95

- Defined by the Company - Defined by Others

Key Partners

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Berkshire Hathaway Inc. n/a 185,674.793 15.38 n/a 1.66 n/a 2.24
Wal-Mart Stores, Inc. n/a 176,235.594 14.25 14.16 0.49 0.47 3.70
Target
  Exxon Mobil Corporation n/a 491,787.026 12.21 12.73 1.31 1.34 4.23
Royal Dutch Shell plc (ADR) n/a 260,977.639 9.60 n/a 0.82 n/a 2.43
BP plc (ADR) n/a 218,385.924 8.40 11.13 0.80 0.71 3.04
Chevron Corporation n/a 193,239.515 10.23 10.79 0.94 0.93 2.78
TOTAL S.A. (ADR) n/a 175,823.241 11.48 11.03 0.99 0.94 3.27
Companhia Vale do Rio Doce (ADR) n/a 131,682.574 13.43 11.13 4.65 3.98 5.11
Eni S.p.A. (ADR) n/a 129,237.189 9.64 10.30 1.11 1.29 2.73
Rio Tinto plc (ADR) n/a 108,595.962 15.75 12.60 4.54 4.01 5.65
Norsk Hydro ASA (ADR) n/a 50,200.535 17.36 15.09 1.54 1.68 2.91
Repsol YPF, S.A. (ADR) n/a 41,228.542 9.79 9.92 0.55 0.59 2.34
Mitsui & Co., Ltd. (ADR) n/a 38,149.079 15.63 11.12 0.97 n/a 1.92
Marathon Oil Corporation n/a 38,073.606 7.66 8.70 0.63 0.52 2.67
Alcan Inc. (USA) n/a 36,945.539 19.50 15.83 1.48 1.45 5.01
Alcoa Inc. n/a 31,365.530 13.81 10.86 1.00 0.97 2.94
Hess Corp. n/a 20,141.574 12.89 11.00 0.69 0.70 2.56
Talisman Energy Inc. (USA) n/a 18,287.094 8.79 15.97 2.48 2.36 3.34
Teck Cominco Limited (USA) n/a 17,970.282 8.59 8.74 2.87 2.69 2.94
Santos Limited (ADR) n/a 6,696.297 16.25 16.58 3.12 3.49 2.56
Denison Mines Corp. n/a 1,864.719 n/a n/a n/a 26.06 2.95
Nippon Mining & Metals Co., Ltd. n/a n/a n/a n/a n/a n/a n/a
Mitsui-Itochu Iron Pty Ltd n/a n/a n/a n/a n/a n/a n/a
Xstrata plc n/a n/a n/a n/a n/a n/a n/a
Mitsubishi Corporation n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Financials

  Buyer Target Combined Entity
Income Statement
Operating Items
Revenue 76,476.0 39,099.0 115,575.0
Other Revenue 0.0 -6,946.0 -6,946.0
Total Revenue 76,476.0 32,153.0 108,629.0
Cost of Revenue 36,686.0 5,044.0 41,730.0
SG&A Expense 24,340.0 13,970.0 38,310.0
Depreciation & Amortization 0.0 2,264.0 2,264.0
Research & Development 0.0 637.0 637.0
Interest Expense 0.0 -3,856.0 -3,856.0
Other Operating Expense 0.0 -210.0 -210.0
Unusual Expense (Income) 0.0 -367.0 -367.0
Total Expenses 61,026.0 17,482.0 78,508.0
Operating Income 15,450.0 14,671.0 30,121.0
Non Operating Items
Interest Expense (Inc.), Net Non-Oprtng -1,304.0 226.0 -1,078.0
Other, Net 564.0 0.0 564.0
Income Before Taxes 14,710.0 14,166.0 28,876.0
Income Taxes 4,370.0 3,632.0 8,002.0
Income After Taxes 10,340.0 10,534.0 20,874.0
Minority Interest (IS) 0.0 -84.0 -84.0
U.S. GAAP Adjustment 0.0 -667.0 -667.0
Net Income - Excl. Xord. Items 10,340.0 9,783.0 20,123.0
Net Income - Incl. Xord. Items 10,340.0 9,783.0 20,123.0
Preferred Dividends -161.0 0.0 -161.0
Income Avail. to Common 10,179.0 9,783.0 19,962.0
Share Items
Basic Avg. Shares Outstanding 2,815.8 3,017.5 5,833.3
Basic EPS - Excl. Xord. Items 3.62 3.24 3.45
Basic EPS - Incl. Xord. Items 3.62 3.24 3.45
Full Dilution Adjustment 122.0 0.0 122.0
Fully Diluted Shares Outstanding 3,377.3 3,033.0 6,410.3
F.D. EPS - Excl. Xord. Items 3.01 3.23 3.14
F.D. EPS - Incl. Xord. Items 3.01 3.23 3.14
Dividends Per Common Share 1.28 0.72 2.00
Balance Sheet
Assets
Cash and Equivalents 5,354.0 n/a 5,354.0
ST Investments 202.0 n/a 202.0
Accounts Receivable 6,629.0 n/a 6,629.0
Inventory 6,819.0 n/a 6,819.0
Prepayments and Advances 3,300.0 n/a 3,300.0
Other Current Assets 1,727.0 n/a 1,727.0
Current Assets 24,031.0 n/a 24,031.0
PPE 34,721.0 n/a 34,721.0
Accum D&A -15,181.0 n/a -15,181.0
PPE, Net 19,540.0 n/a 19,540.0
Goodwill & Intangibles 90,178.0 n/a 90,178.0
Other Assets 0.0 n/a 0.0
Other LT Assets 4,265.0 n/a 4,265.0
Total Assets 138,014.0 n/a 138,014.0
Liabilities
Accounts Payable 5,710.0 n/a 5,710.0
Payable/Accrued 0.0 n/a 0.0
Accrued Expenses 9,586.0 n/a 9,586.0
ST Debt 0.0 n/a 0.0
Curr Port of LTD & Cap Lease Oblg 12,039.0 n/a 12,039.0
Other (Current) Liabilities 3,382.0 n/a 3,382.0
Current Liab. 30,717.0 n/a 30,717.0
LT Debt 23,375.0 n/a 23,375.0
Total LT Debt 23,375.0 n/a 23,375.0
Deferred Taxes 12,015.0 n/a 12,015.0
Other LT Liab. 5,147.0 n/a 5,147.0
Total Liabilities 71,254.0 n/a 71,254.0
Shareholders Equity
Redeemable Preferred 1,406.0 n/a 1,406.0
Common Stock 3,990.0 n/a 3,990.0
Additional Paid in Capital 59,030.0 n/a 59,030.0
Retained Earnings 41,797.0 n/a 41,797.0
Treasure Stock -38,772.0 n/a -38,772.0
Other Equity 617.0 n/a 617.0
ESOP Debt Guarantee -1,308.0 n/a -1,308.0
Total Equity 66,760.0 n/a 66,760.0
Total Liab. & Equity 138,014.0 n/a 138,014.0
Shares Outstanding 3,131.9 n/a 3,131.9
Cash Flow
Operating Cash Flow
CF Net Income 10,340.0 10,534.0 20,874.0
CF Depreciation 3,130.0 2,264.0 5,394.0
CF Deferred Taxes 253.0 0.0 253.0
Other Non-Cash Items 279.0 -1,063.0 -784.0
Change in Working Capital -567.0 -1,259.0 -1,826.0
Total Cash From Operating Activities 13,435.0 10,476.0 23,911.0
Investing Cash Flow (not calculated)
Capital Expenditures -2,945.0 -5,239.0 -8,184.0
Other Investing Cash Flows 462.0 -273.0 189.0
Total Cash From Investing Activities -2,483.0 -5,512.0 -7,995.0
Financing Cash Flow (not calculated)
Dividends Paid -4,209.0 -1,936.0 -6,145.0
Purchase Or Sale of Stock -4,079.0 -2,181.0 -6,260.0
Purchase and Retirement of Debt -4,190.0 -4.0 -4,194.0
Other Financing Cash Flow 0.0 -190.0 -190.0
Total Cash From Financing Activities -12,478.0 -5,412.0 -17,890.0
Exchange Rate Effects 187.0 1.0 188.0
Net Change in Cash -1,339.0 -447.0 -1,786.0
Cash Taxes Paid 4,116.0 3,152.0 7,268.0
Cash Interest Paid 1,330.0 499.0 1,829.0